Morgan Stanley resumed coverage on Baxter with a new price target
$BAX
Medical/Dental Instruments
Health Care
Morgan Stanley resumed coverage of Baxter with a rating of Equal-Weight and set a new price target of $45.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/26/2025 | $42.00 | Buy | Goldman |
| 2/24/2025 | Hold → Buy | Argus | |
| 2/20/2025 | $39.00 | Overweight | Barclays |
| 7/15/2024 | $39.00 → $30.00 | Equal-Weight → Underweight | Morgan Stanley |
| 5/30/2024 | $36.00 | Neutral | Goldman |
| 5/10/2024 | $40.00 | Buy → Hold | TD Cowen |
| 5/30/2023 | $45.00 | Equal-Weight | Morgan Stanley |
| 3/29/2023 | $43.00 | Neutral | UBS |
Goldman resumed coverage of Baxter with a rating of Buy and set a new price target of $42.00
Argus upgraded Baxter from Hold to Buy
Barclays resumed coverage of Baxter with a rating of Overweight and set a new price target of $39.00
8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)
SD - BAXTER INTERNATIONAL INC (0000010456) (Filer)
8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)
4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)
4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)
4 - BAXTER INTERNATIONAL INC (0000010456) (Issuer)